Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers

NCT04795414 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT04795414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04795414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 14, 2021
Completion date
January 31, 2023
Enrollment
1,370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov-2 infection